International Clinical Trial: Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07453069) titled 'Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Freya Biosciences ApS

Condition: Vaginal Dysbiosis

Intervention: Drug: FB-301 Drug: Placebo Other: Chlorhexidine (0.5%) Vaginal Cleanse

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 15, 2026

Target Sample Size...